David Curtis1,2. 1. UCL Genetics Institute, University College London, London, United Kingdom. 2. Centre for Psychiatry, Queen Mary University of London, London, United Kingdom.
Abstract
BACKGROUND: Previous analyses have identified common variants along with some specific genes and rare variants which are associated with risk of hypertension, but much remains to be discovered. METHODS AND RESULTS: Exome-sequenced UK Biobank participants were phenotyped based on having a diagnosis of hypertension or taking anti-hypertensive medication to produce a sample of 66,123 cases and 134,504 controls. Variants with minor allele frequency (MAF) <0.01 were subjected to a gene-wise weighted burden analysis, with higher weights assigned to variants which are rarer and/or predicted to have more severe effects. Of 20,384 genes analysed, 2 genes were exome-wide significant, DNMT3A and FES. Also strongly implicated were GUCY1A1 and GUCY1B1, which code for the subunits of soluble guanylate cyclase. There was further support for the previously reported effects of variants in NPR1 and protective effects of variants in DBH. An inframe deletion in CACNA1D with MAF = 0.005, rs72556363, is associated with modestly increased risk of hypertension. Other biologically plausible genes highlighted consist of CSK, AGTR1, ZYX, and PREP. All variants implicated were rare, and cumulatively they are not predicted to make a large contribution to the population risk of hypertension. CONCLUSIONS: This approach confirms and clarifies previously reported findings and also offers novel insights into biological processes influencing hypertension risk, potentially facilitating the development of improved therapeutic interventions. This research has been conducted using the UK Biobank Resource.
BACKGROUND: Previous analyses have identified common variants along with some specific genes and rare variants which are associated with risk of hypertension, but much remains to be discovered. METHODS AND RESULTS: Exome-sequenced UK Biobank participants were phenotyped based on having a diagnosis of hypertension or taking anti-hypertensive medication to produce a sample of 66,123 cases and 134,504 controls. Variants with minor allele frequency (MAF) <0.01 were subjected to a gene-wise weighted burden analysis, with higher weights assigned to variants which are rarer and/or predicted to have more severe effects. Of 20,384 genes analysed, 2 genes were exome-wide significant, DNMT3A and FES. Also strongly implicated were GUCY1A1 and GUCY1B1, which code for the subunits of soluble guanylate cyclase. There was further support for the previously reported effects of variants in NPR1 and protective effects of variants in DBH. An inframe deletion in CACNA1D with MAF = 0.005, rs72556363, is associated with modestly increased risk of hypertension. Other biologically plausible genes highlighted consist of CSK, AGTR1, ZYX, and PREP. All variants implicated were rare, and cumulatively they are not predicted to make a large contribution to the population risk of hypertension. CONCLUSIONS: This approach confirms and clarifies previously reported findings and also offers novel insights into biological processes influencing hypertension risk, potentially facilitating the development of improved therapeutic interventions. This research has been conducted using the UK Biobank Resource.
Authors: Huay L Tan; Elise Glen; Ana Töpf; Darroch Hall; John J O'Sullivan; Linda Sneddon; Christopher Wren; Peter Avery; Richard J Lewis; Peter ten Dijke; Helen M Arthur; Judith A Goodship; Bernard D Keavney Journal: Hum Mutat Date: 2012-02-14 Impact factor: 4.878
Authors: Patricia Heyn; Clare V Logan; Adeline Fluteau; Rachel C Challis; Tatsiana Auchynnikava; Carol-Anne Martin; Joseph A Marsh; Francesca Taglini; Fiona Kilanowski; David A Parry; Valerie Cormier-Daire; Chin-To Fong; Kate Gibson; Vivian Hwa; Lourdes Ibáñez; Stephen P Robertson; Giorgia Sebastiani; Juri Rappsilber; Robin C Allshire; Martin A M Reijns; Andrew Dauber; Duncan Sproul; Andrew P Jackson Journal: Nat Genet Date: 2018-11-26 Impact factor: 38.330
Authors: Diana L Christian; Dennis Y Wu; Jenna R Martin; J Russell Moore; Yiran R Liu; Adam W Clemens; Sabin A Nettles; Nicole M Kirkland; Thomas Papouin; Cheryl A Hill; David F Wozniak; Joseph D Dougherty; Harrison W Gabel Journal: Cell Rep Date: 2020-11-24 Impact factor: 9.423
Authors: Joseph D Szustakowski; Suganthi Balasubramanian; Erika Kvikstad; Shareef Khalid; Paola G Bronson; Ariella Sasson; Emily Wong; Daren Liu; J Wade Davis; Carolina Haefliger; A Katrina Loomis; Rajesh Mikkilineni; Hyun Ji Noh; Samir Wadhawan; Xiaodong Bai; Alicia Hawes; Olga Krasheninina; Ricardo Ulloa; Alex E Lopez; Erin N Smith; Jeffrey F Waring; Christopher D Whelan; Ellen A Tsai; John D Overton; William J Salerno; Howard Jacob; Sandor Szalma; Heiko Runz; Gregory Hinkle; Paul Nioi; Slavé Petrovski; Melissa R Miller; Aris Baras; Lyndon J Mitnaul; Jeffrey G Reid Journal: Nat Genet Date: 2021-06-28 Impact factor: 38.330